Experimental frontiers for clinical applications: Novel approaches to understanding mechanisms of lymph Node metastases in melanoma

Abstract

Sentinel lymph nodes are the first nodes to receive lymph from primary tumors and are the preferential site of initial metastases. Sentinel nodes show morphology changes that suggests immune modulation with reduced antigen-presenting dendritic cells, activated T lymphocytes, high endothelial venules and transvenular migration of T lymphocytes. Tumor cells generate down-regulatory molecules. We postulate that tumor-induced immune dysfunction facilitates establishment of nodal metastases. Nodal immune modulation can be reversed by granulocyte macrophage colony-stimulating factor (GMCSF), a finding with implications for future therapy to prevent or reverse these nodal metastases.

DOI: 10.1007/s10555-006-8506-4

4 Figures and Tables

Statistics

05010020072008200920102011201220132014201520162017
Citations per Year

105 Citations

Semantic Scholar estimates that this publication has 105 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Essner2006ExperimentalFF, title={Experimental frontiers for clinical applications: Novel approaches to understanding mechanisms of lymph Node metastases in melanoma}, author={Richard Essner}, journal={Cancer and Metastasis Reviews}, year={2006}, volume={25}, pages={257-267} }